128 related articles for article (PubMed ID: 17292332)
1. Muc4 is required for activation of ErbB2 in signet ring carcinoma cell lines.
Yokoyama A; Shi BH; Kawai T; Konishi H; Andoh R; Tachikawa H; Ihara S; Fukui Y
Biochem Biophys Res Commun; 2007 Mar; 355(1):200-3. PubMed ID: 17292332
[TBL] [Abstract][Full Text] [Related]
2. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways.
Jepson S; Komatsu M; Haq B; Arango ME; Huang D; Carraway CA; Carraway KL
Oncogene; 2002 Oct; 21(49):7524-32. PubMed ID: 12386815
[TBL] [Abstract][Full Text] [Related]
3. MUC4 involvement in ErbB2/ErbB3 phosphorylation and signaling in response to airway cell mechanical injury.
Theodoropoulos G; Carraway CA; Carraway KL
J Cell Biochem; 2009 May; 107(1):112-22. PubMed ID: 19288496
[TBL] [Abstract][Full Text] [Related]
4. MUC4 interacts with ErbB2 in human gallbladder carcinoma: potential pathobiological implications.
Miyahara N; Shoda J; Ishige K; Kawamoto T; Ueda T; Taki R; Ohkohchi N; Hyodo I; Thomas MB; Krishnamurthy S; Carraway KL; Irimura T
Eur J Cancer; 2008 May; 44(7):1048-56. PubMed ID: 18397823
[TBL] [Abstract][Full Text] [Related]
5. MUC4 expression and its relation to ErbB2 expression, apoptosis, proliferation, differentiation, and tumor stage in non-small cell lung cancer (NSCLC).
Karg A; Dinç ZA; Başok O; Uçvet A
Pathol Res Pract; 2006; 202(8):577-83. PubMed ID: 16814944
[TBL] [Abstract][Full Text] [Related]
6. Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas.
Kobayashi M; Iwamatsu A; Shinohara-Kanda A; Ihara S; Fukui Y
Oncogene; 2003 Mar; 22(9):1294-301. PubMed ID: 12618754
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms behind signet ring cell carcinoma formation.
Fukui Y
Biochem Biophys Res Commun; 2014 Aug; 450(4):1231-3. PubMed ID: 25019985
[TBL] [Abstract][Full Text] [Related]
8. MUC4 and ERBB2 expression in major and minor salivary gland mucoepidermoid carcinoma.
Weed DT; Gomez-Fernandez C; Pacheco J; Ruiz J; Hamilton-Nelson K; Arnold DJ; Civantos FJ; Zhang J; Yasin M; Goodwin WJ; Carraway KL
Head Neck; 2004 Apr; 26(4):353-64. PubMed ID: 15054739
[TBL] [Abstract][Full Text] [Related]
9. Cell signaling through membrane mucins.
Carraway KL; Ramsauer VP; Haq B; Carothers Carraway CA
Bioessays; 2003 Jan; 25(1):66-71. PubMed ID: 12508284
[TBL] [Abstract][Full Text] [Related]
10. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
[TBL] [Abstract][Full Text] [Related]
11. MUC4 and ErbB2 expression in squamous cell carcinoma of the upper aerodigestive tract: correlation with clinical outcomes.
Weed DT; Gomez-Fernandez C; Yasin M; Hamilton-Nelson K; Rodriguez M; Zhang J; Carraway KL
Laryngoscope; 2004 Aug; 114(8 Pt 2 Suppl 101):1-32. PubMed ID: 15284539
[TBL] [Abstract][Full Text] [Related]
12. Sequestration and segregation of receptor kinases in epithelial cells: implications for ErbB2 oncogenesis.
Carraway CA; Carraway KL
Sci STKE; 2007 Apr; 2007(381):re3. PubMed ID: 17426346
[TBL] [Abstract][Full Text] [Related]
13. Production and localization of Muc4/sialomucin complex and its receptor tyrosine kinase ErbB2 in the rat lacrimal gland.
Arango ME; Li P; Komatsu M; Montes C; Carraway CA; Carraway KL
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2749-56. PubMed ID: 11687512
[TBL] [Abstract][Full Text] [Related]
14. ErbB3 expression predicts tumor cell radiosensitization induced by Hsp90 inhibition.
Dote H; Cerna D; Burgan WE; Camphausen K; Tofilon PJ
Cancer Res; 2005 Aug; 65(15):6967-75. PubMed ID: 16061682
[TBL] [Abstract][Full Text] [Related]
15. Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor.
Komatsu M; Jepson S; Arango ME; Carothers Carraway CA; Carraway KL
Oncogene; 2001 Jan; 20(4):461-70. PubMed ID: 11313977
[TBL] [Abstract][Full Text] [Related]
16. MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma.
Tsutsumida H; Goto M; Kitajima S; Kubota I; Hirotsu Y; Wakimoto J; Batra SK; Imai K; Yonezawa S
Lung Cancer; 2007 Feb; 55(2):195-203. PubMed ID: 17126950
[TBL] [Abstract][Full Text] [Related]
17. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
[TBL] [Abstract][Full Text] [Related]
18. Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line.
Nagy P; Friedländer E; Tanner M; Kapanen AI; Carraway KL; Isola J; Jovin TM
Cancer Res; 2005 Jan; 65(2):473-82. PubMed ID: 15695389
[TBL] [Abstract][Full Text] [Related]
19. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer.
Senapati S; Chaturvedi P; Sharma P; Venkatraman G; Meza JL; El-Rifai W; Roy HK; Batra SK
Br J Cancer; 2008 Sep; 99(6):949-56. PubMed ID: 18781152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
